SCHEDULE 13G/A: Macquarie Entities Disclose 4.67% Passive Stake in Prestige Consumer Healthcare

Macquarie Group Limited and its subsidiaries have filed an amended Schedule 13G, revealing a passive beneficial ownership of 4.67% in Prestige Consumer Healthcare Inc. as of December 31, 2024.

Summary

• Macquarie Group Limited, along with its subsidiaries Macquarie Management Holdings Inc. and Macquarie Investment Management Business Trust, jointly filed an Amendment No. 1 to Schedule 13G.
• The filing discloses a beneficial ownership of 2,309,017 common shares of Prestige Consumer Healthcare Inc.
• This aggregate amount represents 4.67% of the class of common shares.
• Macquarie Management Holdings Inc. and Macquarie Investment Management Business Trust each hold sole voting and sole dispositive power over all 2,309,017 shares.
• The filing indicates that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: A Schedule 13G filing is a routine disclosure of beneficial ownership and does not inherently convey positive or negative sentiment regarding the issuer's performance or prospects. It indicates a passive investment.

Positives

• The disclosure of a significant passive stake by a major financial institution like Macquarie Group can be viewed as a vote of confidence in Prestige Consumer Healthcare Inc.'s long-term prospects.
• The filing confirms that the investment is for ordinary course of business and not for control, suggesting stability in the ownership structure.

Future Outlook

This Schedule 13G filing is a disclosure of current beneficial ownership and does not contain forward-looking statements or guidance regarding the issuer's future performance or strategic outlook.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

This filing represents a routine disclosure of a passive investment by a large global financial services group in a consumer healthcare company. It reflects ongoing institutional portfolio management within the sector, indicating continued interest in established consumer brands.

Comparison to Industry Standards

• A 4.67% passive stake is a common size for institutional investments, indicating a significant but non-controlling position within a diversified portfolio.
• This level of ownership is typical for investment advisers and parent holding companies that manage assets for various clients or funds, aligning with standard practices for institutional investors in the consumer goods and healthcare sectors.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant institutional holdings, confirming a major financial group's passive investment in Prestige Consumer Healthcare Inc.

Next Steps

• Routine ongoing compliance with SEC reporting requirements for beneficial ownership will continue as long as the reporting persons maintain a reportable stake in Prestige Consumer Healthcare Inc.

Key Dates

Keywords

Prestige Consumer Healthcare, Macquarie Group, Schedule 13G, beneficial ownership, common shares, institutional investment, passive stake, SEC filing